In partnership with Takeda, Enso designed, developed, and globally deployed the Zero Bleeds platform, consisting of a haemophilia patient mobile app, and a connected Haemophilia Treatment Center web application.
The intuitive patient-centric app assists with treatment compliance and record keeping, while providing secure real-time monitoring data to the treating physician. Physicians can configure patient specific alerts based on parameters such as compliance or bleed events, and easily update the patient’s prescription and infusion schedule remotely. In some regions the platform supports patient-initiated ordering of drug infusions and streamlines government/payer reporting.